Scarica l'app Stockscreener
26.12
1.84%
-0.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Moderna Inc Borsa (MRNA) Ultime notizie
IBM and Moderna have simulated the longest mRNA pattern without AI — they used a quantum computer instead - Live Science
ABC Arbitrage SA Buys Shares of 54,198 Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Envestnet Asset Management Inc. Sells 12,212 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
UTMB, Moderna hit with vaccine research cancellation month after publishing new mRNA data - The Business Journals
Moderna to Cut 10% of Staff to Offset Slowing Covid Business - MSN
OVERSEA CHINESE BANKING Corp Ltd Has $1.16 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
XTX Topco Ltd Purchases 27,237 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
CytomX (CTMX) Q2 Revenue Drops 26% - The Motley Fool
Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here? - Yahoo Finance
Is Moderna Stock A Sell After Cutting Its Sales Outlook — Again? - Investor's Business Daily
Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow - MSN
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Banco Santander S.A. - MarketBeat
Q3 Earnings Forecast for Moderna Issued By Leerink Partnrs - MarketBeat
LPL Financial LLC Grows Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moors & Cabot Inc. Reduces Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna (NASDAQ:MRNA) Releases Earnings Results, Beats Estimates By $0.86 EPS - MarketBeat
RFK Jr. ends mRNA vaccine support; Moderna, other Mass. firms affected - WCVB
US HHS cancels 22 BARDA mRNA vaccine contracts - BioWorld MedTech
Public health experts dismayed by RFK Jr.'s defunding of mRNA vaccine research : ShotsHealth News - NPR
Moderna’s stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals - MSN
HHS abandons mRNA vaccine research - BioPharma Dive
US health agency to wind down mRNA vaccine development - Reuters
The intrapreneur edge: What we learned at Moderna about the need to act like a startup - The Globe and Mail
Robust Growth in Mrna Therapeutics Process Development Market - openPR.com
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 - Amarillo Globe-News
RFK Jr. Axes 22 mRNA Vaccine Projects Under BARDA - BioSpace
HHS halts funding for mRNA vaccine activities (MRNA:NASDAQ) - Seeking Alpha
RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing Safer, Broader Strategies' - Benzinga
Moderna Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca - MSN
Moderna (NASDAQ:MRNA) Shares Gap DownHere's Why - MarketBeat
Wealthquest Corp Buys Shares of 36,587 Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
US Health Department Pulls Back on Funding mRNA Vaccine Research - Bloomberg.com
14,589 Shares in Moderna, Inc. (NASDAQ:MRNA) Purchased by Banque Cantonale Vaudoise - MarketBeat
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease - Milwaukee Journal Sentinel
Barclays Has Lowered Expectations for Moderna (NASDAQ:MRNA) Stock Price - MarketBeat
Moderna: RSV Upside Slim, Cash Burn Heavy (NASDAQ:MRNA) - Seeking Alpha
July Layoffs Skyrocket 487% YOY With Merck Cuts - BioSpace
Let’s make a deal? Big Pharma execs express varying views on their M&A future - PharmaVoice
Cancer Vaccine Research Report 2025-2035 | Market Accelerates with Key Players Like Merck and Moderna, Backed by Pharma-Biotech Collaborations and Academic Partnerships - Yahoo Finance
Zurcher Kantonalbank Zurich Cantonalbank Sells 134,443 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Holdings Cut by Pacer Advisors Inc. - MarketBeat
Traders Buy Large Volume of Call Options on Moderna (NASDAQ:MRNA) - MarketBeat
Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates - El Paso Times
UK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTech - Pocono Record
Moderna Seeks To Be Cleared In $5B COVID Vax Patent Case - Law360
BofA Securities lowers Moderna stock price target to $24 on COVID reliance - Investing.com
EU regulator backs Moderna's updated COVID vaccine - MSN
Moderna Tops Vaccine Expectations But Trims Future Outlook - Finimize
Moderna stock falls as UBS reiterates Buy rating amid cost cuts - Investing.com Canada
How the U.S. mRNA Therapeutics Market Will Evolve by 2032 - openPR.com
Moderna Q2 Earnings Review: Downsizing Triggers Selloff, But I'm Long-Term Bullish (MRNA) - Seeking Alpha
0.24%
3.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):